Telesta Therapeutics was a biotechnology company focused on the licensing/acquisition and development of transformational therapeutics for the treatment of serious human diseases, such as cancer, immune diseases, and targeted rare diseases.
Prometic Life Sciences Inc. acquired Telesta on October 31, 2016.
Location: Canada
Member count: 11-50
Founded date: 1999
Investors 1
| Date | Name | Website |
| - | Omega Fund... | omegafunds... |